個人經歷
教育與研究經歷
2006年本科畢業於
武漢大學生命科學學院,2012年博士畢業於武漢大學細胞與
發育生物學專業,隨後加入中科院上海生化細胞所,歷任博士後和副研究員,研究CRISPR介導的小鼠胚胎以及
精原幹細胞中的基因修復,在國際上首次證明了CRISPR可以在動物個體水平進行遺傳疾病的修復和治療。2015年,證明了單倍體幹細胞可以作為CRISPR文庫的載體,被注射到卵母細胞,直接高效率地產生相應基因被敲除的小鼠。2015-2018年,在哈佛醫學院和
波士頓兒童醫院工作期間,開發了
造血幹細胞中基於CRISPR的基因治療技術,通過高效激活胎兒
血紅蛋白基因的表達來治療
地中海貧血及鐮刀狀貧血疾病,文章發表於Nature Medicine,相關療法已經進入了臨床實驗階段。多項工作均發表在國際期刊上,包括Nature Medicine(1 篇)、Cell Stem Cell(2 篇)、Nature Biotechnology(1 篇)、Nature Genetics(1 篇)和Cell Research(2 篇),這些工作引起了國際同行的廣泛關注,總引用次數達到900餘次(來源於Google Scholar數據)。2018年入選
華東師範大學 “紫江優秀青年學者”高層次人才引進項目,擔任研究員,博士生導師。
社會兼職
Journalof Molecular Cell Biology編委
研究方向
2.造血幹細胞增殖和分化的信號網路及表觀遺傳調控
4.通過CRISPR文庫篩選和鑑定腫瘤免疫新靶點
學術成果
發表文章
1.Wu Y#, Zeng J#, Roscoe BP, Liu P, Yao Q,Lazzarrotto CR, Clement MK, Cole MA, Luk K, Baricordi C, Shen AH, Esrick EB, ManisJP, Dorfman DM, Williams DA, Biffi A, Brugnara C, Biasco L, Brendel C, PinelloL, Tsai SQ, Wolfe SA, Bauer DE (2019) Highly efficient therapeutic gene editingof human hematopoietic stem cells. Nature Medicine 25(5):776-783.
2.Gehrke JM, Cervantes O, Clement MK,Wu Y,Zeng J, Bauer DE, Pinello L, Joung JK* (2018) An APOBEC3A-Cas9 base editor withminimized bystander and off-target activities. Nature Biotechnology 36(10):977-982
3.Canver MC, Lessard S, Pinello L,Wu Y,Ilboudo Y, Stern EN, Needleman AJ, Galacteros F, Brugnara C, Kutlar A, McKenzieC, Reid M, Chen DD, Das PP, A Cole M, Zeng J, Kurita R, Nakamura Y, Yuan G-C,Lettre G, Bauer DE*, Orkin SH* (2017) Variant-aware saturating mutagenesisusing multiple Cas9 nucleases identifies regulatory elements attrait-associated loci. Nature Genetics 49(4): 625-634
3.Zhong C, Xie Z, Yin Q, Dong R, Yang S,Wu Y,Yang L, Li J (2016) Parthenogenetic haploid embryonic stem cells efficientlysupport mouse generation by oocyte injection. Cell research 26(1): 131-134
4.Bai M, Liang D, Wang Y, Li Q,Wu Y*, Li J*(2016) Spermatogenic Cell-Specific Gene Mutation in Mice via CRISPR-Cas9.Journal of genetics and genomics 43(5): 289-296 (*Co-corresponding author)
5.Zhong C#, Yin Q#, Xie Z#, Bai M#, Dong R#, TangW, Xing Y, Zhang H, Yang S, Chen L, Bartolomei M, Ferguson-Smith A, Li D, YangL*,Wu Y*, and Li J* (2015) CRISPR-Cas9-Mediated Genetic Screening in Mice withHaploid Embryonic Stem Cells Carrying a Guide RNA Library. Cell stem cell 17:221–232 (*Co-corresponding author)
6.Liu P, Dou X, Liu C, Wang L, Xing C, Peng G,Chen J, Yu F, Qiao Y, Song L,Wu Y, Yue C, Li J, Han JD, Tang K, Jing N* (2015)Histone deacetylation promotes mouse neural induction by restrictingNodal-dependent mesendoderm fate. Nature communications 6: 6830
7.Wu Y#, Zhou H#, Fan X#, Zhang Y#, Zhang M#,Wang Y, Xie Z, Bai M, Yin Q, Liang D, Tang W, Liao J, Zhou C, Liu W, Zhu P, GuoH, Pan H, Wu C, Shi H, Wu L*, Tang F*, Li J* (2015) Correction of a geneticdisease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stemcells. Cell research 25: 67-79 (EDITOR'S CHOICE 2015 of Cell research)
8.Wu Y#, Liang D#, Wang Y, Bai M, Tang W, BaoS, Yan Z, Li D, Li J* (2013) Correction of a genetic disease in mouse via useof CRISPR-Cas9. Cell stem cell 13: 659-662 (Research highlights by Nature;reported by The Scientist; recommendation in F1000)
9.Wu Y, Zhao S, Tian H, He Y, Xiong W, Guo L,Wu Y* (2013) CPK3-phosphorylated RhoGDI1 is essential in the development ofArabidopsis seedlings and leaf epidermal cells. Journal of experimental botany64: 3327-3338
榮譽獎項